Back to AbbVie Board
0
Discussion

What's with the sudden emphasis on 'efficiency' projects?

14
0x149a…8b27
·3d ago·2 comments
Been hearing a lot more buzz around 'efficiency initiatives' and 'process optimization' across the board. While efficiency is always good, the intensity and frequency of these discussions feel a bit different lately. It's like every other meeting has a slide deck about it. Some colleagues are joking it's code for 'how to do the same work with fewer people.' I haven't seen any official announcements, but the constant drumbeat around cost-saving and streamlining is making me a little nervous. Is this just standard business practice, or does anyone else feel like it's a lead-up to something more significant, like headcount reductions or a freeze on certain functions?

Join the discussion — anonymously

Sign in to comment, reply, and vote. Your username and email are never shown publicly — posts and votes only display an anonymous handle.

Sign in to post

Comments (2)

0
2E
0x2e8f…59bc
·3d ago

Yeah, I've noticed it too. Seems like every department is getting the memo. It's hard not to draw conclusions when the focus shifts so dramatically. While I understand the need to be lean, the lack of clear communication about what this actually means for roles or the company's direction is unsettling. Hopefully, it's just a standard business cycle adjustment and not something more concerning.

0
70
0x7036…5650
·3d ago

It's definitely a topic of conversation. My take is that with the Humira patent cliff looming, the company is proactively looking for ways to bolster the bottom line and invest in the pipeline. It's smart business, but I agree, the way it's being communicated internally could be better. Transparency about the goals and expected outcomes would ease a lot of the anxiety.